| Product NDC: | 16590-492 |
| Proprietary Name: | GABAPENTIN |
| Non Proprietary Name: | GABAPENTIN |
| Active Ingredient(s): | 400 mg/1 & nbsp; GABAPENTIN |
| Administration Route(s): | ORAL |
| Dosage Form(s): | CAPSULE |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 16590-492 |
| Labeler Name: | STAT RX USA LLC |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA078428 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20091124 |
| Package NDC: | 16590-492-90 |
| Package Description: | 90 CAPSULE in 1 BOTTLE (16590-492-90) |
| NDC Code | 16590-492-90 |
| Proprietary Name | GABAPENTIN |
| Package Description | 90 CAPSULE in 1 BOTTLE (16590-492-90) |
| Product NDC | 16590-492 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | GABAPENTIN |
| Dosage Form Name | CAPSULE |
| Route Name | ORAL |
| Start Marketing Date | 20091124 |
| Marketing Category Name | ANDA |
| Labeler Name | STAT RX USA LLC |
| Substance Name | GABAPENTIN |
| Strength Number | 400 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Anti-epileptic Agent [EPC],Decreased Central Nervous System Disorganized Electrical Activity [PE] |